CAMBRIDGE, Mass. (AP) _ Genocea Biosciences Inc. (GNCA) on Thursday reported a loss of $13.3 million in its fourth quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 19 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

For the year, the company reported that its loss narrowed to $33.2 million, or 48 cents per share. Revenue was reported as $1.6 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNCA at https://www.zacks.com/ap/GNCA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News